Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements
Reviewed 29 sourcesPublished by PepVault
Fiber, whey, Akkermansia, curcumin, berberine and food order, each with its best trial's weight change, set beside Wegovy and Zepbound's label numbers.

- Last reviewed
- Sources
- 29
- Questions
- 9
- Compounds
- 5
The short answer
Some foods do raise your own GLP-1, but none comes close to the drugs. Whey protein before a meal more than doubled GLP-1 after it, and eating carbohydrates last raised it 38%. In weight, pooled supplement trials find 0 to about 4 kg more than placebo. Semaglutide took off about 13 kg more than placebo in 68 weeks, tirzepatide about 19 kg in 72 (our arithmetic from its label).
Evidence: High for the drugs' weight results (large placebo-controlled label trials); low to moderate for the GLP-1 rises from protein and food order (small randomized meal trials) and for each supplement's weight effect (pooled trials of mixed quality, many short); the Akkermansia protein result is from mice.

Do natural GLP-1 boosters work?
They move the hormone, and the scale only a little. GLP-1 is a hormone your gut releases after you eat: it slows the stomach, tells the pancreas to release insulin and turns down appetite8. Protein, fiber and the order you eat in all change how much of it you release. In one trial, 50 g of whey protein drunk before breakfast raised total GLP-1 after the meal by 141% in 15 adults with type 2 diabetes10. Eating protein and vegetables 10 minutes before the carbohydrates raised it 38% against eating the carbohydrates first11.
The catch is how long your own GLP-1 lasts. An enzyme in the blood, DPP-4, cuts it up almost as soon as it is released, much of it before it leaves the gut8. In people with type 2 diabetes, half an hour after an injection of natural GLP-1, about 9 in 10 of the added GLP-1 molecules in the blood were already the cut, inactive form9. The drugs are built to survive that, which is why a meal's bump and a weekly shot end up so far apart.

How much weight does each natural option take off?
Each candidate's best human evidence, as the trials report it. A pooled number comes from a meta-analysis (many trials combined) and is the difference against placebo, the dummy pill; a single trial shows both groups. 1 kg is 2.2 lb.
| Candidate | What it does to GLP-1 or appetite | Best weight result in people | Who, how long |
|---|---|---|---|
| Psyllium (fiber) | Thickens the gut's contents and slows the stomach | 3.70 kg more than placebo in one pooled analysis15; 0.28 kg and not significant in another16 | Adults with overweight or obesity (first pool); adults, 22 trials (second pool) |
| Glucomannan (konjac fiber) | Swells in water and fills the stomach | 1.36 kg, low certainty15; 0.22 kg and not significant in 8 trials17 | Adults with overweight or obesity |
| Oligofructose (inulin-type fiber), 21 g a day | Ghrelin, the hunger hormone, down; PYY, a fullness hormone, up; GLP-1 unchanged | -1.03 kg vs +0.45 kg on placebo18 | 48 adults with overweight, 12 weeks |
| Akkermansia, pasteurized | Raised GLP-1 in mice19; a higher GLP-1 rise after a glucose drink in people, in an exploratory analysis21 | 2.27 kg more than placebo, not significant20 | 32 adults with overweight and insulin resistance, 3 months |
| Mixed probiotics | Not measured in the pool | No significant change in body weight23 | 10 trials, 633 adults, 8 to 12 weeks |
| Whey protein before meals (17 g with 5 g guar fiber) | Slower stomach emptying, lower sugar after meals | No difference in weight; HbA1c 0.1 point lower14 | 79 adults with type 2 diabetes, 12 weeks |
| Carbohydrates last | GLP-1 up 38% after the meal11 | -3.6 lb vs -2.6 lb on standard advice, no difference between groups13 | 45 adults with prediabetes, 16 weeks |
| Curcumin | Not measured | 0.59 kg more than control24 | 50 trials |
| Cinnamon | Not measured | 0.92 kg more than control25 | 21 trials, 1,480 adults |
| Yerba mate, 3 g a day | Not measured | -0.7 kg vs +2.8 kg on placebo, not significant; body fat fell26 | 30 adults with obesity, 12 weeks |
| Capsaicin (chili) | Burns about 58 more kcal a day | Not measured in that pool27 | 9 trials |
| Berberine | Covered in our berberine guide | 0.88 kg more than control28 | 23 trials |
Where a candidate beats placebo at all, the pooled difference runs from under 1 kg to about 4 kg, mostly in trials of a few months.
How do Ozempic, Wegovy, Mounjaro and Zepbound compare?
For scale, the four labels' own placebo-controlled weight results: Wegovy and Zepbound were tested for weight in people without diabetes; Ozempic and Mounjaro were tested for blood sugar in type 2 diabetes, where weight loss is smaller (Wegovy’s diabetes trial: -9.6%1) and the trials shorter.
| Label | Trial | Who, how long | Weight: drug vs placebo |
|---|---|---|---|
| Wegovy 2.4 mg1 | Study 2 (STEP 1) | 1,961 adults with obesity or overweight, 68 weeks | -14.9% vs -2.4% (-15.3 kg vs -2.6 kg6) |
| Zepbound 15 mg2 | Study 1 (SURMOUNT-1) | 2,539 adults with obesity or overweight, 72 weeks | -20.9% vs -3.1%7 |
| Ozempic 1 mg3 | Monotherapy trial | 388 adults with type 2 diabetes, 30 weeks | -4.7 kg vs -1.2 kg |
| Mounjaro 15 mg4 | Monotherapy trial | 478 adults with type 2 diabetes, 40 weeks | -7.8 kg vs -1.0 kg |
On Zepbound's starting weight of about 105 kg, 20.9% is roughly 22 kg, about 19 kg more than placebo (our arithmetic from the label’s baseline weights and percentages2). That is about five times psyllium’s 3.70 kg, the largest supplement result above, and about 20 times berberine’s 0.88 kg, over a longer trial. Our pages on Wegovy (pepvault.app/drugs/wegovy), Zepbound (pepvault.app/drugs/zepbound), Ozempic (pepvault.app/drugs/ozempic) and Mounjaro (pepvault.app/drugs/mounjaro) carry each label in full.
Why does a food bump not act like the shot?
Because the drug does not wear off between meals. Semaglutide, in Ozempic and Wegovy, is bound to albumin, the blood's main carrier protein, and built to resist DPP-4, so its half-life (the time for half of it to clear) is about one week3. Tirzepatide's is about five days2. Your own GLP-1 is released with each meal and mostly inactive within half an hour [8, 9]. The chart shows a weekly shot's level, which stays up for the whole week.
Try it
How Semaglutide builds up
An estimate from a half-life of about 6.9 days, one dose a week for four weeks. The shape of the level, not a measurement.
Byetta was not made from food either. Its exenatide is a synthetic peptide first found in a lizard, the Gila monster (Heloderma suspectum), and it lasts hours, not days: its half-life is 2.4 hours5. Its page: pepvault.app/drugs/byetta.
Which fiber works best: psyllium, glucomannan or inulin?
Psyllium has the strongest single number and the least agreement. A network meta-analysis of 111 trials, which ranks supplements against each other, gave it 3.70 kg with moderate certainty, the largest figure in its summary15. A separate pool of 22 psyllium trials found 0.28 kg and no significant effect16.
Oligofructose gave the clearest single trial: 21 g a day for 12 weeks took off 1.03 kg while the placebo group gained 0.45 kg, and people reported eating less18. It lowered ghrelin and raised PYY, another fullness hormone, and left GLP-1 unchanged18. So a fiber can curb appetite without being a GLP-1 booster at all.
Do probiotics or Akkermansia raise GLP-1?
Akkermansia muciniphila is a gut bacterium that is scarcer in people with obesity20. In mice on a high-fat diet, a protein it releases, P9, raised GLP-1 and improved blood sugar19. That is a mouse result. In people, the first trial gave 32 adults pasteurized Akkermansia for three months: insulin sensitivity improved 28.6% against placebo, and weight fell 2.27 kg more, a difference the trial could not confirm20.
The larger 2026 trial, run by the company that makes the product, gave 142 adults with metabolic syndrome 30 billion pasteurized cells a day for four months. Its main measure, insulin sensitivity, did not differ from placebo; in exploratory analyses the GLP-1 rise after a glucose drink was higher at three months, most in people who started with little Akkermansia21. A five-strain mix with Akkermansia (WBF-011), tested by the company that makes it, lowered HbA1c 0.6 point against placebo in 76 adults with type 2 diabetes over 12 weeks, with no change in weight22.
Does eating protein and vegetables first help?
It is the best-measured free GLP-1 effect. In 16 adults with type 2 diabetes, eating the carbohydrates last cut the blood-sugar rise after the meal by 53% and raised GLP-1 by 38%, against eating them first11. A crossover trial in 16 healthy adults found the vegetables-then-meat-then-rice order gave the highest GLP-1 of five orders12. The trial order looks like this:
- Serve the whole meal as you usually would.
- Eat the vegetables and the protein (meat, fish, eggs, tofu) first.
- Wait about 10 minutes, the gap the trial used11.
- Eat the bread, rice, pasta or potatoes last.
Over months, the effect on weight is small. In 45 adults with prediabetes, 16 weeks of carbohydrates-last advice lost 3.6 lb against 2.6 lb on standard advice, and the two groups did not differ13. A whey and guar drink before two meals a day for 12 weeks slowed the stomach and lowered HbA1c 0.1 point, with no change in weight14. It is a blood-sugar habit, not a weight-loss treatment.
PepVault's Food log records protein and fiber for every meal, by photo, barcode or a few words, against one daily target with protein first. Track your food in PepVault
What about curcumin, cinnamon, yerba mate, capsaicin and berberine?
- Curcumin, from turmeric: 0.59 kg more than control across 50 trials, and 0.80 kg for the forms made to absorb better24. Our curcumin vs turmeric guide (pepvault.app/guides/curcumin-vs-turmeric) covers the forms.
- Cinnamon: 0.92 kg across 21 trials, with wide variation between them25.
- Yerba mate: in 30 adults over 12 weeks, body fat fell against placebo; weight did not differ significantly26.
- Capsaicin: about 58 more kcal burned a day across 9 trials, and about 70 in people with a BMI over 2527; no weight change was pooled.
- Berberine: 0.88 kg across 23 trials28, and no difference in belly (visceral) fat or liver fat after six months in 337 adults with obesity and fatty liver29. Our berberine vs metformin vs a GLP-1 guide (pepvault.app/guides/berberine-vs-metformin-vs-glp-1) has the full picture.
How do you tell whether something you try is working?
Weigh in on the same morning each week and give a change four weeks before you judge it. Most effects in the table are under 2 kg over two to four months, so a single reading tells you little.
In PepVault you log a weigh-in in a few seconds, and the trend line shows whether a change you tried moved your weight over weeks, not days. Track your weight in PepVault
Commonly reported: a fuller stomach for an hour or two after a fiber drink or protein shake before a meal, and gas or bloating in the first weeks of a fiber supplement; the glucomannan trials recorded stomach discomfort, diarrhea and constipation17.
When to get help On a GLP-1 with insulin or a sulfonylurea, the label already warns that blood sugar can run low3; tell your prescriber before adding anything that lowers it further, and treat signs of low blood sugar as a reason to check your glucose.
Sources
- Wegovy (semaglutide) prescribing information, section 14, Table 8. Novo Nordisk. DailyMed SPL version 19, June 30, 2026. dailymed.nlm.nih.gov
- Zepbound (tirzepatide) prescribing information, sections 12.3 and 14, Table 2. Eli Lilly. DailyMed SPL version 40, September 2, 2026. dailymed.nlm.nih.gov
- Ozempic (semaglutide) prescribing information, sections 5.5, 10, 12.3 and 14 (monotherapy trial). Novo Nordisk. DailyMed SPL version 20, June 10, 2026. dailymed.nlm.nih.gov
- Mounjaro (tirzepatide) prescribing information, section 14, Table 4. Eli Lilly. DailyMed SPL version 40, September 2, 2026. dailymed.nlm.nih.gov
- Byetta (exenatide) prescribing information, sections 11 and 12.3. AstraZeneca. DailyMed SPL version 26, September 8, 2025. dailymed.nlm.nih.gov
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021. PubMed 33567185
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022. PubMed 35658024
- Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007. PubMed 17928588
- Deacon CF et al. Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. Diabetes. 1995. PubMed 7657039
- Jakubowicz D et al. Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia. 2014. PubMed 25005331
- Shukla AP et al. Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. BMJ Open Diabetes Res Care. 2017. PubMed 28989726
- Sun L et al. Postprandial glucose, insulin and incretin responses differ by test meal macronutrient ingestion sequence (PATTERN study). Clin Nutr. 2020. PubMed 31053510
- Shukla AP et al. A randomized controlled pilot study of the food order behavioral intervention in prediabetes. Nutrients. 2023. PubMed 37892527
- Watson LE et al. A whey/guar preload improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: a 12-week, single-blind, randomized, placebo-controlled trial. Diabetes Obes Metab. 2019. PubMed 30520216
- Shahinfar H et al. Comparative effects of nutraceuticals on body weight in adults with overweight or obesity: a systematic review and network meta-analysis of 111 randomized clinical trials. Pharmacol Res. 2023. PubMed 37778464
- Darooghegi Mofrad M et al. The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020. PubMed 30880409
- Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014. PubMed 24533610
- Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009. PubMed 19386741
- Yoon HS et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021. PubMed 33820962
- Depommier C et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019. PubMed 31263284
- Suenaert P et al. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome. Gut Microbes. 2026. PubMed 42343233
- Perraudeau F et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020. PubMed 32675291
- Ko J et al. Effects of probiotics and synbiotics on body weight management in individuals with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Phys Act Nutr. 2026. PubMed 42438848
- Unhapipatpong C et al. The effect of curcumin supplementation on weight loss and anthropometric indices: an umbrella review and updated meta-analyses of randomized controlled trials. Am J Clin Nutr. 2023. PubMed 36898635
- Yazdanpanah Z et al. Effects of cinnamon supplementation on body weight and composition in adults: a systematic review and meta-analysis of controlled clinical trials. Phytother Res. 2020. PubMed 31800140
- Kim SY et al. Anti-obesity effects of yerba mate (Ilex paraguariensis): a randomized, double-blind, placebo-controlled clinical trial. BMC Complement Altern Med. 2015. PubMed 26408319
- Zsiborás C et al. Capsaicin and capsiate could be appropriate agents for treatment of obesity: a meta-analysis of human studies. Crit Rev Food Sci Nutr. 2018. PubMed 28001433
- Elahi Vahed I et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes. 2026. PubMed 41310257
- Lei L et al. Berberine and adiposity in diabetes-free individuals with obesity and MASLD: a randomized clinical trial (BRAVO). JAMA Netw Open. 2026. PubMed 41543854
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.